Crossmark

Dose optimization of piperacillin/tazobactam, cefepime, and ceftazidime for carbapenem-resistant Pseudomonas aeruginosa isolates in Türkiye

Published Online: 2024-11-15

Published Print: 2025-01

Authors

Buyukyanbolu, Ecem

Gill, Christian M.

Genc, Leyla

Karakus, Mehmet

Comert, Fusun

Otlu, Baris

Aktas, Elif

Nicolau, David P.
License Information

Text and Data Mining valid from 2024-11-15

Version of Record valid from 2024-11-15
More Information

Article History

Received: 6 August 2024

Accepted: 6 November 2024

First Online: 15 November 2024

Declarations

:

: Human Ethics and Consent to Participate declarations: not applicable.

: The authors declare no competing interests.

Document is current